Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma

Yasuyuki Mizutani, Mitsuhiro Fujishiro, Eizaburo Ohno et al.|BMC Cancer|2022

Cited by 32